Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396006
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2006-11-03
Brief Title:
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 Human Alpha 1 - Proteinase Inhibitor
Sponsor:
Baxalta now part of Shire
Organization:
Takeda
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2007-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-03
First Submit QC Date:
November 3 2006
Study First Post Date:
2006-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-01-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-17
Last Update Post Date:
2021-05-13
Last Update Post Date Type:
ACTUAL